Industries > Pharma > Clinical Oncology Next Generation Sequencing (NGS) Market Report 2019-2029

Clinical Oncology Next Generation Sequencing (NGS) Market Report 2019-2029

By Component (Sequencing Platform, Sequencing Products, End-users and Reagents, Services), by Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing (SBS), Real Time Sequencing (SMRT), Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing, Others), by Application (Whole Tumor Genome Sequencing, Whole Tumor Exome Sequencing, Targeted Tumor Genome Profiling, Tumor Transcriptome Sequencing, Tumor-normal Comparisons, Others), by End-user (Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories, Others)

PAGES: 167
PRODUCT CODE: PHA0488

DOWNLOAD FREE SAMPLE
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

Clinical Oncology Next Generation Sequencing (NGS) – our new study reveals trends, R&D progress, and predicted revenues
Where is the Clinical Oncology Next Generation Sequencing (NGS) market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2029, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 242-page report provides 35 tables, 190 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Clinical Oncology Next Generation Sequencing (NGS) market. See how to exploit the opportunities.

Forecasts to 2029 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2029, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Component profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 4 segmentations of the Clinical Oncology Next Generation Sequencing (NGS) market, with forecasts for 4 Components, 8 Technologies, 6 Applications and 4 End Users, each forecasted at a global and regional level.

Global Clinical Oncology Next Generation Sequencing (NGS) Market by Component
• Sequencing Platform
• Sequencing Products
• End Users and Reagents
• Services

Global Clinical Oncology Next Generation Sequencing (NGS) Market by Technology
• Microarray
• Ion Semiconductor Sequencing
• Pyro-Sequencing
• Synthesis Sequencing (SBS)
• Real Time Sequencing (SMRT)
• Ligation Sequencing
• Reversible Dye Termination Sequencing
• Nano -Pore Sequencing
• Others

Global Clinical Oncology Next Generation Sequencing (NGS) Market by Application
• Whole Tumor Genome Sequencing
• Whole Tumor Exome Sequencing
• Targeted Tumor Genome Profiling
• Tumor Transcriptome Sequencing
• Tumor -normal Comparisons
• Others

Global Clinical Oncology Next Generation Sequencing (NGS) Market by End User
• Hospital Laboratories
• Clinical Research Organizations
• Diagnostic Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:

• North America:
• US
• Canada

• Latin America:
• Brazil
• Mexico
• Rest of Latin America

• Western Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Nordic
• Benelux
• Rest of Western Europe

• Eastern Europe:
• Russia
• Poland
• Rest of Eastern Europe

• Asia-Pacific:
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• Rest of Asia-Pacific

• MEA:
• GCC Countries
• South Africa
• Northern Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Oncology Next Generation Sequencing (NGS) market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2029.

Leading companies and the potential for market growth
Overall world revenue for Clinical Oncology Next Generation Sequencing (NGS) will surpass $3.87 billion in 2019, our work calculates. We predict strong revenue growth through to 2029.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Clinical Oncology Next Generation Sequencing (NGS) Market report helps you
In summary, our 253-page report provides you with the following knowledge:

• Revenue forecasts to 2029 for 4 segmentations of the Clinical Oncology Next Generation Sequencing (NGS) market, with forecasts for 4 Components, 8 Technologies, 6 Applications and 4 End Users, each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2029 for 6 regional and 21 key national markets – See forecasts for the Clinical Oncology Next Generation Sequencing (NGS) market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.

• Stimulates and restrains companies and the market

• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Clinical Oncology Next Generation Sequencing (NGS) market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Clinical Oncology Next Generation Sequencing (NGS) Sequencing market and leading companies. You will find data, trends and predictions.

Get our report today The Clinical Oncology Next Generation Sequencing (NGS) Market Forecast 2019-2029: Revenue Prospects by Component (Sequencing platform, Sequencing products, End users and Reagents, Services), by Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing (SBS), Real Time Sequencing (SMRT), Ligation Sequencing, Reversible Dye Termination Sequencing, Nano -Pore Sequencing, Others), by Application (Whole Tumor Genome Sequencing, Whole Tumor Exome Sequencing, Targeted Tumor Genome Profiling, Tumor Transcriptome Sequencing, Tumor -normal Comparisons, Others), by End user (Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories, Others) and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Clinical Oncology Next Generation Sequencing (NGS) Market Report 2019-2029

    Download sample pages

    Complete the form below to download your free sample pages for Clinical Oncology Next Generation Sequencing (NGS) Market Report 2019-2029

      Latest Pharma news

      Visiongain Publishes Bioreactors Market Report 2023-2033

      The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.

      29 September 2023

      READ

      Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

      The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

      27 September 2023

      READ

      Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

      The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

      25 September 2023

      READ

      Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

      The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

      21 September 2023

      READ